MAM
GMED icon

Melqart Asset Management’s Globus Medical GMED Stock Holding History

Melqart Asset Management’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-218,913
Closed -$11.7M – 64
2024
Q1 		$11.7M Buy
+218,913
New +$11.8M 0.73% 34

Other funds holding GMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BAM
Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Melqart Asset Management's GMED Position: Q2 2024 in Review

Melqart Asset Management sold out of Globus Medical (GMED) in Q2 2024, closing a stake of 218,913 shares — an estimated $11.7M sold.

Melqart Asset Management first reported a position in GMED in Q1 2024 and held it in 1 quarter. The position peaked at $11.7M in Q1 2024. 450 funds tracked by Wall St. Rank hold GMED as of Q2 2024.

  • Melqart Asset Management reported no remaining Globus Medical position as of Q2 2024 after selling out during the quarter.
  • Melqart Asset Management sold 218,913 Globus Medical shares in Q2 2024, an estimated $11.7M.
  • Melqart Asset Management first reported a position in Globus Medical in Q1 2024 and held it in 1 quarter.
  • Melqart Asset Management's Globus Medical position peaked at $11.7M in Q1 2024.
  • 450 funds tracked by Wall St. Rank held Globus Medical as of Q2 2024.

Based on Melqart Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.